Exposure to bioactive compounds from nutrition, pharmaceuticals, environmental contaminants or other lifestyle habits may affect the human organism. To gain insight into the effects of these influences, as well as the fundamental biochemical mechanisms behind them, individual molecular profiling seems to be a promising tool and may support the further development of predictive, preventive and personalised medicine.
We developed an assay, called metabo-tip for the analysis of sweat, collected from fingertips, using mass spectrometry—by far the most comprehensive and sensitive method for such analyses. To evaluate this assay, we exposed volunteers to various xenobiotics using standardised protocols and investigated their metabolic response.
As early as 15 min after the consumption of a cup of coffee, 50 g of dark chocolate or a serving of citrus fruits, significant changes in the sweat composition of the fingertips were observed, providing relevant information in regard to the ingested substances. This included not only health-promoting bioactive compounds but also potential hazardous substances. Furthermore, the identification of metabolites from orally ingested medications such as metamizole indicated the applicability of this assay to observe specific enzymatic processes in a personalised fashion. Remarkably, we found that the sweat composition fluctuated in a diurnal rhythm, supporting the hypothesis that the composition of sweat can be influenced by endogenous metabolic activities. This was further corroborated by the finding that histamine was significantly increased in the metabo-tip assay in individuals with allergic reactions.
Metabo-tip analysis may have a large number of practical applications due to its analytical power, non-invasive character and the potential of frequent sampling, especially regarding the individualised monitoring of specific lifestyle and influencing factors. The extraordinarily rich individualised metabolomics data provided by metabo-tip offer direct access to individual metabolic activities and will thus support predictive preventive personalised medicine.
It is now widely known that lifestyle choices are pivotal for a person’s health and life quality, and it is estimated that at least 40% and up to 95% of chronic illnesses can be traced back to lifestyle risk factors (e.g. smoking, lack of physical activity and dietary habits) [1, 2]. Moreover, a positive correlation between the adoption of healthy lifestyle choices and a reduced risk of mortality as well as postponing or even avoiding many types of chronic illnesses such as cancer, cardiovascular diseases and metabolic syndrome has been demonstrated [1, 3,4,5,6,7,8]. Insulin resistance, abnormal lipid metabolism, diabetes and hypertension are risk factors highly correlated with obesity [9,10,11], while smoking is known to cause several cancers, especially of the lung and upper airways [12, 13]. In contrast, regular physical activities as well as healthy eating habits such as the Mediterranean diet  have already shown to reduce the risk of several chronic conditions such as cardiovascular disease [15, 16], to play a protective role in cancer prevention , to promote longevity  and to decrease the risk of developing metabolic syndrome and type 2 diabetes . Observational studies suggest that lifestyle changes, mainly dietary , can improve the immune system and reduce the risk of recurrence of certain types of cancers, such as ovarian cancer . Therefore, fast and efficient monitoring of biomarkers reflecting individual lifestyle patterns could play a preventive role in the development of chronic disorders.
Monitoring of individual metabolic responses to xenobiotic exposures
The investigation of metabolic response to environmental exposures is an emerging field of research in toxicology [22, 23]. The so-called exposome includes exogenous exposure not only to the environment, diet or lifestyle factors but also to biological processes reflecting internal responses to exposure [24,25,26]. For example, a chronic low-dose exposure to mycotoxins, which are frequently detected as natural contaminants in foods, has already been associated with the onset of various diseases. The analysis of mycotoxins as biomarkers for exposure to contaminated food was successfully performed using plasma, serum, urine and milk samples [27, 28]. The origin of many metabolites, which are either endogenously produced, originate from the gut microbiome, or come from the environment via nutrition or smoking, is already being investigated in great detail . In particular, serum metabolomics has successfully revealed several biomarkers which have improved our understanding of disease mechanisms and which are being used in clinical settings for the diagnosis of diseases as well as in the monitoring of therapeutic outcomes .
A fast and non-invasive sweat collection procedure in humans hyphenated with an ultra-sensitive LC–MS/MS approach
A comprehensive analysis of endogenous processes related to the uptake and individual metabolism of xenobiotics requires sensitive analytical techniques in addition to non-invasive and fast sampling methods, allowing short interval sampling and therefore enabling kinetic time-course measurements in humans [31, 32]. The analysis of sweat from the fingertips fulfils these requirements and supports compliance of test subjects. Over decades, fingerprints have been used to identify individuals and more recently play an important role in lifestyle monitoring via imaging mass spectrometry . Exogenous compounds found in bug sprays and sunscreens as well as food oils, alcohols and citrus fruits were detected in fingerprints, offering relevant chemical information about the tested person . Moreover, fingerprints are used to detect illicit drugs and their metabolites [35, 36]. In contrast to the investigation of fingerprints, the analysis of sweat has been successfully proven in diagnostic medicine to enable the monitoring of individual metabolic and health states [37, 38]. Sweat is mainly composed of water (99%), but includes also numerous substances such as electrolytes, lactate, pyruvate, urea, amino acids, proteins, peptides, fatty acids, hormones and xenobiotics (e.g. cosmetics, medications and drugs including ethanol) . Antibodies and cytokines detected in sweat may serve as potential biomarkers for diseases  and, as already demonstrated, for disease states in cystic fibrosis  and active tuberculosis . Moreover, cortisol has been successfully quantified in human eccrine sweat, demonstrating the potential of finger sweat analysis in regard to monitor endogenous processes related to stress .
The power of individual metabolic profiling in the context of PPPM
Only recently, we successfully demonstrated kinetic time-course measurements of metabolic activities in humans, indicating that finger sweat analyses may become a valuable tool for precision medicine . In contrast to other minimally invasive approaches [43, 44], the presented non-invasive metabolomics assay works quickly and easily while offering tremendous investigative power. We have termed it “metabo-tip”. Indeed, the ingestion of many bioactive compounds contained in food may become detectable via metabo-tip within minutes after consumption. Applying mathematical modelling strategies, it was possible to overcome critical normalisation challenges and to obtain quantitative measures for individual metabolic properties . In this project, we investigated metabo-tip in regard to monitoring lifestyle parameters such as the presence of endogenous and exogenous bioactive compounds or exposure to toxins contained in foods or beverages. These parameters could be described by time-dependent metabolic patterns detected in sweat from the fingertip. This basic research study was conducted to explore potential fields of application of metabo-tip analysis in the clinical routine, thereby supporting the further development of predictive, preventive and personalised medicine (PPPM). Thus, the potential of metabo-tip analysis in order to monitor individual metabolic responses upon the uptake of xenobiotics and potentially unexpected toxins was investigated. The observation of metabolic diurnal rhythms and distinct individual responses to potentially adverse exposure promises successful future applications of metabo-tip analysis not only in the general assessment of individual lifestyle parameters but also in the context of PPPM.
Material and methods
Reagents and chemicals
LC–MS grade formic acid, methanol and water used for chromatographic separation as well as for preparation of internal standards and samples were purchased from VWR (Germany). Xenobiotic and metabolic standards were obtained either from Sanova Pharma GmbH (Austria), from Sigma-Aldrich (Austria), or from Honeywell Fluka (GER). Filter papers (standardised to 1 cm2) used for sampling were stamped out of fuzz-free paper from Kimtech Science (USA).
Several volunteers were recruited after giving written, informed consent for the different studies as outlined in Table 1. These experiments were approved by the ethical committee of the University of Vienna (no. 00337). Volunteers may be part of more than one study (A–E). Gender distribution of participants was equally balanced between male and female and their ages ranged from 20 to 50 years. Some studies (C–E) required a fasting period of 12 h for caffeinated foods (chocolate, energy bars) and beverages (coffee, tea, energy drinks) before beginning with the experiment in order to avoid interferences with the investigation of xenobiotic metabolism. Finger sweat samples were collected just before donors consumed a 50-g chocolate bar or a double espresso (0 min). Finger sweat samples were thereafter collected in short intervals as outlined in Table 1. In studies A and B, the general lifestyle of volunteers was monitored. There were no dietary restrictions placed on the test subjects.
Collection of sweat from the fingertip
Finger sweat samples were collected as previously published . In short, filter papers were stamped out of fuzz-free paper to get a circular area of 1 cm2, filter papers were pre-wetted with 3 µl of LC–MS grade water and stored in 0.5-ml Eppendorf Tubes. For each sweat collection, donors cleaned their hands with warm tap water and then dried their hands with disposable paper towels. Donors kept their hands open in the air at room temperature for 1 min. Then, the sampling unit was placed between thumb and index finger with clean tweezers and held for 1 min. Filters were transferred back to labelled 0.5-ml Eppendorf tubes using clean tweezers and stored at 4 °C until sample preparation.
Each finger sweat sample collected on filter paper was extracted with 120 µl of extraction solution (an aqueous solution of 1 pg µl−1 caffeine-trimethyl-D9 with 0.2% formic acid). Metabolites were extracted via repeated pipetting of the extraction solvent 15 times. The filter paper was pelleted on the bottom of the Eppendorf Tube and the supernatant was transferred into HPLC glass vials equipped with a 200-µl V-Shape glass insert (Macherey–Nagel GmbH & Co.KG) and analysed by LC–MS/MS. To determine background metabolites or potential contaminants, blank filter papers were additionally extracted in the same manner. Standard solutions were prepared in methanol in a concentration of 1 mg ml−1. After that, they were diluted to concentrations of 100 pg µl−1 and 10 pg µl−1.
Chromatographic separation was performed on a Vanquish UHPLC system (Thermo Fisher Scientific) and analysed in an untargeted fashion with a hybrid instrument consisting of a quadrupole mass filter and an orbitrap mass analyser (Q Exactive HF, Thermo Fisher Scientific). A reversed phase Kinetex XB-C18 column (100 Å, 2.6 µm, 100 × 2.1 mm, Phenomenex Inc.) was used to separate analytes present in finger sweat samples. Mobile phase A consisted of water with 0.2% formic acid and mobile phase B of methanol with 0.2% formic acid. The following gradient was applied: 1–5% B in 0.3 min and then 5–40% B from 0.3–4.5 min, followed by a column washing phase of 1.4 min at 80% B and a re-equilibration phase of 1.6 min at 1% B resulting in a total runtime of 7.5 min. Flow rate was set to 500 µl min−1 and the injection volume was 10 µl. Electrospray ionisation was performed in positive as well as negative ionisation mode. MS scan range was m/z 100–1000 and the resolution was set to 60,000 (at m/z 200) for MS1 and 15,000 (at m/z 200) for MS2. A top 4 method was applied and dynamic exclusion was set to 6 s. Collision energy was 30 eV. Instrument control was performed with Xcalibur software (Thermo Fisher Scientific).
Raw files generated by the Q Exactive HF were searched in the Compound Discoverer Software 3.1 (Thermo Fisher Scientific) applying a user-defined workflow. All identified compounds with a match factor ≥ 80 were manually reviewed using Xcalibur 4.0 Qual browser (Thermo Fisher Scientific) and the obtained MS2 spectra were compared to reference spectra taken from mzcloud (Copyright © 2013–2020 HighChem LLC, Slovakia). A maximum retention time shift of 0.1 min was allowed and the mass tolerance was restricted to 10 ppm for MS1 and MS2. Identified compounds were also verified using purchased analytical standards applying the same LC–MS method. The Tracefinder Software 4.1 (Thermo Fisher Scientific) was used for peak integration and calculation of peak areas. Generated batch tables were exported and further process with Microsoft Excel, GraphPad Prism (for two-tailed, paired t-tests) and the Perseus  (for principal component analysis) software. ACD/Labs’ ChemSketch (Freeware) 2020.1.1 was used to draw structures.
Both food and beverage consumption leave characteristic imprints on finger sweat composition and enable conclusions to be drawn about the general lifestyle of individuals
Figure 1a shows extracted ion chromatograms identifying caffeine, 7-, 3- and 1-methylxanthine as well as catechin and epicatechin in a finger sweat sample of an individual 15 min after consumption of 50-g dark chocolate. None of these substances was detectable in the finger sweat of individuals before consumption; the significant increase of these compounds in finger sweat after chocolate consumption could be reproduced in a controlled study with ten different individuals (Fig. 1b). Furthermore, the levels of different caffeine metabolites after chocolate intake were compared to those after drinking a cup of coffee. Although both caffeine and theobromine are contained in chocolate as well as coffee, different levels of these two compounds found in finger sweat enabled the identification of the respective consumption groups (Fig. 1c). Paraxanthine is the catabolic metabolite of caffeine and apparently accumulates in regular coffee consumers [46, 47]. In our experiment, we could confirm this finding in individuals consuming coffee regularly through elevated baseline levels of paraxanthine in finger sweat (Fig. 1d). Thus, a metabolic property detected in finger sweat may be related to individual lifestyle preferences, such as coffee consumption. Obviously, nutrition is a major contributor to individual lifestyle habits. The monitoring of individual metabolic responses such as food intolerances upon the intake of specific foods and beverages as outlined below may gain great relevance in the further development of PPPM.
Cigarette smoke, pharmaceuticals and exposure to environmental toxins leave characteristic imprints on finger sweat composition
Not only a specific diet but also personal habits such as smoking and regular use of pharmacological drugs will result in characteristic changes in finger sweat. Moreover, metabo-tip has the potential to detect even trace amounts of pesticides as demonstrated in Fig. 2. The consumption of an orange allowed for the identification of natural bioactive compounds such as flavonoids (nobiletin, hesperidin and tangeritin) together with pesticides such as enilconazole (Fig. 2a). In addition, metabo-tip was applied to detect smoking of tobacco (cigarettes) in finger sweat via characteristic compounds such as nicotine and anatabine (Fig. 2b). The simultaneous detection of precursor molecules and their metabolites such as nicotine, cotinine and 3-hydroxycotinine facilitates individual metabolic profiling (Fig. 2b). In the case that xenobiotics are not directly detectable, evidence can be found by the detection of specific metabolites. For example, the pain killer metamizole was not detectable in sweat, but after consumption of metamizole, a group of metamizole-derived metabolites could be detected in finger sweat, as demonstrated in Fig. 2c. The power of metabo-tip with respect to the detection of even trace amounts of substances with noxious effects, as summarised in Fig. 3, demonstrates its great potential as tool for PPPM supporting clinical practice. In this way, not only patient’s compliance regarding the intake of specific prescribed medications may be monitored but also a molecular risk assessment analysis upon the intake of toxins such as cigarette smoke can be performed.
Sweat composition provides a wide spectrum of information regarding individual lifestyle
Metabo-tip not only allows the detection of specific compounds after consumption of a certain food or medication but also enables comprehensive, untargeted screening of exogenous bioactive compounds, for instance from cosmetics or environmental pollutants. In addition, it detects specific markers for general lifestyle habits (Fig. 3, Supplementary Table). Based on previously published studies [48, 49], it could be assumed that basic compounds are more likely to get transported into sweat ducts; however, our results do not seem to discriminate between analytes based on their pKA values, therefore allowing for a comprehensive metabolic profile (Supplementary Table with listed pKA values). The combined detection of exogenous compounds as well as endogenously produced metabolites results in a specific molecular signature in the finger sweat of each individual. Exposure to bioactive compounds as well as to various medications and drugs can be easily detected. Moreover, environmental pollutants such as fungicides, mycotoxins and compounds derived from plastic containers such as bisphenol S and melamine are detectable (Supplementary Table) and may be of great relevance concerning individual health. Thus, the wide array of information obtained from finger sweat analysis may reveal information about the exposition to toxins and general health status of an individual. This important property of metabo-tip may open up many remarkable opportunities for a more systematic investigation of exposure to toxins and individual responses thereupon, thus improving risk assessment and extending our opportunities to assess an individual’s health status.
Metabo-tip analysis reveals diurnal fluctuations in metabolism and individual endogenous responses
Principal component analysis (PCA) of finger sweat samples collected from three donors in the morning and evening over a time period of 30 days revealed fluctuating differences in finger sweat composition with the possibility to distinguish between these individuals based on their general lifestyle (Fig. 4a, b). Donor A and donor B could not be completely separated by PCA which might be contributed to a similar lifestyle as these donors share the same household. Intriguingly, a regular shift of metabolites in a diurnal rhythm was observed (Fig. 4c). Analysis of the PCA loadings plot suggested caffeine, theobromine, theophylline, paraxanthine and amino acids as most influential compounds (Fig. 4d).
This time series analysis was also used to assess the biogenic monoamine histamine, which serves both as a neurotransmitter and as a modulator in inflammatory responses. Figure 4e exemplifies the levels of histamine of an individual determined by metabo-tip analysis on consecutive days. Histamine peaks correlated with symptoms associated with food intolerance and allergy reported on the corresponding days. This observation indicated that specific individual responses to food consumption are detectable by metabo-tip analysis. Obviously, different individuals may respond rather differently to a given food, typically documented by gossips rather than molecular analyses. The capability of metabo-tip to detect individual molecular responses opens another highly relevant field of PPPM research.
Diagnosis and treatment of chronic disease are often difficult, because these diseases often have multiple causes—as evidenced in case of arteriosclerosis, type II diabetes, cancer or neurodegenerative diseases. Actually they may be caused or promoted by an imbalance of metabolic homoeostasis due to long-lasting stress. The investigation of metabolic imbalances in humans has been difficult though such investigation is crucial to predictive preventive personalised medicine (PPPM) improvement . Due to its dynamic nature, metabolomic measurements call for repeated analyses in a narrow timeframe. Blood sampling is therefore hardly feasible as it leads to compliance issues. Non-invasive methods would be preferable but the analysis of urine, for instance, does not allow repeated time series analyses in a narrow timeframe because urine is collected in the bladder prior to sampling. Saliva may suffer from contaminants such as bacteria and food as well as from mucous glycoproteins which may interfere with metabolite extraction and which may impair sensitivity of measurement. Sweat is only available in limited amounts, and the risk of potential contamination from the skin also causes quantification challenges. To overcome some of these obstacles, we investigated sweat collected from clean fingertips via metabo-tip. This procedure is fast, non-invasive and easy to use, thereby supporting multiple measurements within a short timeframe, and ensuring good compliance by the test subjects . A determination of individual enzymatic activities and a management strategy to cope with normalisation issues, related to the total amount of sweat collected per sample, has already been demonstrated . Here, we evaluated whether this analytical method could detect specific substances that would reflect upon lifestyle habits which may be relevant to health to be determined.
Extending current PPPM strategies by monitoring individual metabolic responses to the uptake of xenobiotics
We demonstrated that the uptake of as little as 0.2 mg of a chemical compound may be sufficient to be detected by metabo-tip analysis, and investigated if this approach was limited to basic compounds showing higher solubility in the slightly acidic sweat pH [49, 51]. Plotting the identified substances versus pKA values did not show any relation, suggesting no discrimination of substances based on their pKA (Supplementary Table). Thus, it seems that metabo-tip analysis may provide a representative overview of stable substances we are exposed to. Present data therefore suggest a broad applicability of metabo-tip. The detection of bioactive compounds such as flavonoids and even pesticides after the consumption of oranges (Fig. 2a) demonstrated the practicability of the assay.
Furthermore, the metabolism of xenobiotics could be observed using metabo-tip analysis as demonstrated in the case of xanthines, nicotine and metamizole (Figs. 1 and 2). Individual differences in the expression of P450 isoenzymes  may account for individual variations in drug effects and toxicity . As demonstrated by us previously, proteomics and eicosanoid analysis revealed that the consumption of coffee may have significant pro- or anti-inflammatory effects in an individualised fashion . In that study, age, sex, coffee consumption habits as well as the metabolic kinetics of caffeine in blood of each individual were ruled out as predictive parameters accounting for pro- or anti-inflammatory effects. Thus, the combination of different “-omics” approaches, especially the inclusion of metabolic profiling, may be of great relevance regarding PPPM and individual risk assessment . As metabo-tip analysis allows for the profiling of xenobiotic exposure and the associated metabolic activities, it will greatly support more systematic studies to improve current PPPM strategies.
Metabo-tip: a novel tool for the detection of endogenous metabolic responses
We have observed an apparent correlation between allergic symptoms and histamine detected by metabo-tip analysis (Fig. 4), which opens the opportunity to define biochemical signatures of some adverse effects. Metabo-tip analyses will allow us to investigate apparent detrimental effects with scientific rigour, enabling reasonable conclusions to be made regarding risk assessment. Furthermore, the presented analytical workflow offers the opportunity to monitor individual responses to plant-derived bioactive compounds, especially flavonoids, which are intensely discussed in the context of PPPM because of their beneficial impact on carcinogenesis [56, 57]. Specifically, the detection of histamine points to the enormous power of metabo-tip for clinical studies related to food intolerance. So far, only volunteers reporting no acute medical disorders were included in our studies. Thus, a systematic and large-scale evaluation of the predictive power of metabo-tip analysis in patients suffering from various medical disorders needs to be performed in order to evaluate the power of metabo-tip for clinical routine applications.
The opportunities offered by metabo-tip analysis are raising many questions. Only large-scale studies will allow us to decide, e.g., whether the apparent diurnal rhythm observed by metabo-tip in this study (Fig. 4) was related to endogenous factors (e.g. through circadian regulation), or rather exogenous factors (such as regular nutrient patterns or repeated exposure to xenobiotics). Furthermore, technical improvements regarding robustness, sensitivity and throughput may also support the development of stress monitoring devices as well as therapy monitoring strategies, bringing about crucial progress in the field of PPPM.
Sweat may serve as specific source for reactive oxygen species-associated metabolites
We have recently reported that erythrocytes interfere with reactive oxygen species (ROS) formation so efficiently that ROS-dependent T-cell activation is blocked by the mere presence of erythrocytes . This observation clearly implies that the formation of ROS-dependent metabolites in blood may be inhibited as well. Inflammatory activation of leukocytes typically takes place in the interstitium, and actually sweat reflects the constitution of interstitial fluid [59, 60] which is free from erythrocytes. Therefore, the analysis of sweat may provide the advantage of including ROS-associated metabolites in the analysis which may otherwise be missing in blood. On the other hand, labile and reactive metabolites may react already at the skin surface due to the presence of oxygen and get lost for meaningful evaluation. These aspects highlight the huge potential of metabo-tip only to be realised by more basic research.
Ways to translate metabo-tip into clinical practice and its potential impact on supporting PPPM concepts
Up until now, metabo-tip was exclusively used in the framework of basic research projects to identify and uncover its power and applicability in various research areas. In this context, a comprehensive metabolomic screening approach was conducted which requires specially trained personnel in the field of LC–MS/MS and data analysis. The translation of metabo-tip analysis as tool for PPPM in the clinical routine will require some practical adaptions. Based on the screening approach, a panel of molecules serving as biomarkers should be selected for targeted analysis, facilitating data management and evaluation. Regarding the general cost–benefit of metabo-tip analysis in clinical practice, it will prove most cost-effective in the long run since the principal costs will fall to the purchase and installation of a suitable LC–MS/MS system.
Thus, a large number of PPPM-related applications, potentially offered by metabo-tip analysis, warrant larger scale studies. The non-invasive and painless sampling procedure in combination with high-throughput analysis enables the systematic monitoring of individuals in short intervals. Hence, the opportunity of frequent sampling makes it even possible to carry out specific metabolic in vivo studies in humans. Up until now, the most comprehensive metabolic studies were conducted using in vitro cell culture model systems. As demonstrated previously, those experiments often suffer from unexpected influencing factors such as the composition of fetal calf serum . The advantage of metabo-tip analysis is the facilitated use of humans as model system for comprehensive metabolic studies in vivo. This possibility enables the monitoring of a plethora of metabolic intervention studies in individuals in the context of PPPM such as the monitoring of food intolerances, the examination of individual lifestyle changes in association with the general health status and risk assessment and the monitoring of the intake of prescribed medications in clinical practice.
Strengths and limitations
Metabo-tip analysis is a fast, non-invasive, painless and easy to use strategy, thereby supporting metabolic measurements in a short timeframe, and ensuring optimal compliance by the test subjects. These strengths enable the individualised monitoring of metabolites and the assessment of metabolic kinetics of individuals as response to various stimuli. Nevertheless, some limitations of metabo-tip analysis have to be considered. Up until now, metabo-tip was applied for basic research projects only. The applicability of metabo-tip in clinical routine has still to be evaluated systematically by setting up targeted LC–MS/MS methods applied to larger study cohorts. The small amount of sweat used for metabo-tip analysis requires highly sensitive analytical approaches for metabolomic analyses with the drawback that even small contaminations on the fingertip of test subjects can already impede and distort the analysis. Furthermore, the absolute quantification of metabolites represents a true challenge. However, using the kinetic profile of biochemically related pairs of molecules such as caffeine and its metabolites, i.e. xanthines, has already been proven to support normalisation and determine individual sweat flux rates.
Conclusions and outlook
We conclude that metabo-tip offers a great opportunity to support the further development of PPPM strategies due to its non-invasive character and the possibility of painless sampling in a narrow timeframe while providing rich molecular information. In this way, personalised molecular profiles can be generated allowing us to observe individual metabolic reactions to exogenous and/or endogenous stimuli or challenges. Ongoing research will establish the relation of individual molecular patterns obtained by metabo-tip with disease states or risk for diseases. We thus suggest that metabo-tip may have a large number of clinical applications ranging from diagnostic applications such as the early detection of food intolerances to the monitoring and validation of therapeutic strategies.
Raw data is secured and available on request.
Coefficient of variation
Liquid chromatography mass spectrometry
- m/z :
Mass over charge
Normalised area under the curve
Principle component analysis
- pKA :
Acid dissociation constant
Predictive preventive personalised medicine
Reactive oxygen species
Anand P, Kunnumakara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 2008;25(9):2097–116.
Glade MJ. Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition. 1999;15(6):523–6.
Schwingshackl L, Schwedhelm C, Galbete C, Hoffmann G. Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis. Nutrients. 2017. https://doi.org/10.3390/nu9101063 .
Bodai BI, Nakata TE, Wong WT, Clark DR, Lawenda S, Tsou C, et al. Lifestyle medicine: a brief review of its dramatic impact on health and survival. Perm J. 2018;22:17–25.
Bishehsari F, Voigt RM, Keshavarzian A. Circadian rhythms and the gut microbiota: from the metabolic syndrome to cancer. Nat Rev Endocrinol. 2020. https://doi.org/10.1038/s41574-020-00427-4 .
Lee DH, Nam JY, Kwon S, Keum N, Lee JT, Shin MJ, et al. Lifestyle risk score and mortality in Korean adults: a population-based cohort study. Sci Rep. 2020. https://doi.org/10.1038/s41598-020-66742-y .
VanWormer JJ, Boucher JL, Sidebottom AC, Sillah A, Knickelbine T. Lifestyle changes and prevention of metabolic syndrome in the Heart of New Ulm Project. Prev Med Rep. 2017;6:242–5.
Key TJ, Bradbury KE, Perez-Cornago A, Sinha R, Tsilidis KK, Tsugane S. Diet, nutrition, and cancer risk: what do we know and what is the way forward? BMJ. 2020. https://doi.org/10.1136/bmj.m511 .
Beavis AL, Smith AJB, Fader AN. Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management. Int J Womens Health. 2016;8:151–67.
Bornhorst C, Russo P, Veidebaum T, Tornaritis M, Molnar D, Lissner L, et al. The role of lifestyle and non-modifiable risk factors in the development of metabolic disturbances from childhood to adolescence. Int J Obesity. 2020;44(11):2236–45.
Wengle JG, Hamilton JK, Manlhiot C, Bradley TJ, Katzman DK, Sananes R, et al. The ‘Golden Keys’ to health - a healthy lifestyle intervention with randomized individual mentorship for overweight and obesity in adolescents. Paed Child Health. 2011;16(8):473–8.
Ma YL, Li MD. Establishment of a strong link between smoking and cancer pathogenesis through DNA methylation analysis. Sci Rep. 2017. https://doi.org/10.1038/s41598-017-01856-4 .
West R. Tobacco smoking: health impact, prevalence, correlates and interventions. Psychol Health. 2017;32(8):1018–36.
Grosso G, Buscemi S, Galvano F, Mistretta A, Marventano S, La Vela V, et al. Mediterranean diet and cancer: epidemiological evidence and mechanism of selected aspects. Bmc Surg. 2013. https://doi.org/10.1186/1471-2482-13-S2-S14 .
Warburton DE, Bredin SS. Reflections on physical activity and health: what should we recommend? Can J Cardiol. 2016;32(4):495–504.
Menotti A, Kromhout D, Blackburn H, Fidanza F, Buzina R, Nissinen A, et al. Food intake patterns and 25-year mortality from coronary heart disease: cross-cultural correlations in the Seven Countries Study. Eur J Epidemiol. 1999;15(6):507–15.
D’Alessandro A, De Pergola G, Silvestris F. Mediterranean Diet and cancer risk: an open issue. Int J Food Sci Nutr. 2016;67(6):593–605.
Di Daniele N, Noce A, Vidiri MF, Moriconi E, Marrone G, Annicchiarico-Petruzzelli M, et al. Impact of Mediterranean diet on metabolic syndrome, cancer and longevity. Oncotarget. 2017;8(5):8947–79.
Lacatusu CM, Grigorescu ED, Floria M, Onofriescu A, Mihai BM. The Mediterranean diet: from an environment-driven food culture to an emerging medical prescription. Int J Env Res Pub He. 2019. https://doi.org/10.3390/ijerph16060942 .
Rodriguez Paris V, Solon-Biet SM, Senior AM, Edwards MC, Desai R, Tedla N, et al. Defining the impact of dietary macronutrient balance on PCOS traits. Nat Commun. 2020. https://doi.org/10.1038/s41467-020-19003-5 .
Yeganeh L, Harrison C, Vincent AJ, Teede H, Boyle JA. Effects of lifestyle modification on cancer recurrence, overall survival and quality of life in gynaecological cancer survivors: a systematic review and meta-analysis. Maturitas. 2018;111:82–9.
Costa JG, Vidovic B, Saraiva N, do Ceu Costa M, Del Favero G, Marko D, et al. Contaminants: a dark side of food supplements? Free Radic Res. 2019;53(1):1113–35.
Rietjens IMCM, Dussort P, Gunther H, Hanlon P, Honda H, Mally A, et al. Exposure assessment of process-related contaminants in food by biomarker monitoring. Arch Toxicol. 2018;92(1):15–40.
Warth B, Spangler S, Fang M, Johnson CH, Forsberg EM, Granados A, et al. Exposome-scale investigations guided by global metabolomics, pathway analysis, and cognitive computing. Anal Chem. 2017;89(21):11505–13.
Wild CP. The exposome: from concept to utility. Int J Epidemiol. 2012;41(1):24–32.
Vermeulen R, Schymanski EL, Barabasi AL, Miller GW. The exposome and health: where chemistry meets biology. Science. 2020;367(6476):392–6.
Warth B, Braun D, Ezekiel CN, Turner PC, Degen GH, Marko D. Biomonitoring of mycotoxins in human breast milk: current state and future perspectives. Chem Res Toxicol. 2016;29(7):1087–97.
Sarkanj B, Ezekiel CN, Turner PC, Abia WA, Rychlik M, Krska R, et al. Ultra-sensitive, stable isotope assisted quantification of multiple urinary mycotoxin exposure biomarkers. Anal Chim Acta. 2018;1019:84–92.
Bar N, Korem T, Weissbrod O, Zeevi D, Rothschild D, Leviatan S, et al. A reference map of potential determinants for the human serum metabolome. Nature. 2020. https://doi.org/10.1038/s41586-020-2896-2 .
Wishart DS. Emerging applications of metabolomics in drug discovery and precision medicine. Nat Rev Drug Discov. 2016;15(7):473–84.
Lin Y-S, Weibel J, Landolt H-P, Santini F, Meyer M, Brunmair J, et al. Daily caffeine intake induces concentration-dependent medial temporal plasticity in humans: a multimodal double-blind randomized controlled trial. Cereb Cortex. 2021. https://doi.org/10.1093/cercor/bhab005 .
Brunmair J, Niederstaetter L, Neuditschko B, Bileck A, Slany A, Janker L, et al. Finger sweat analysis enables short interval metabolic biomonitoring in humans. bioRxiv. 2020. https://doi.org/10.1101/2020.11.06.369355 .
Faulds H. The permanence of finger-print patterns. Nature. 1917;98:388–9.
Hinners P, O’Neill KC, Lee YJ. Revealing individual lifestyles through mass spectrometry imaging of chemical compounds in fingerprints. Sci Rep. 2018. https://doi.org/10.1038/s41598-018-23544-7 .
Bailey MJ, Bradshaw R, Francese S, Salter TL, Costa C, Ismail M, et al. Rapid detection of cocaine, benzoylecgonine and methylecgonine in fingerprints using surface mass spectrometry. Analyst. 2015;140(18):6254–9.
Groeneveld G, de Puit M, Bleay S, Bradshaw R, Francese S. Detection and mapping of illicit drugs and their metabolites in fingermarks by MALDI MS and compatibility with forensic techniques. Sci Rep. 2015. https://doi.org/10.1038/srep11716 .
Harshman SW, Pitsch RL, Schaeublin NM, Smith ZK, Strayer KE, Phelps MS, et al. Metabolomic stability of exercise-induced sweat. J Chromatogr B. 2019. https://doi.org/10.1016/j.jchromb.2019.121763 .
Katchman BA, Zhu ML, Christen JB, Anderson KS. eccrine sweat as a biofluid for profiling immune biomarkers. Proteom Clin Appl. 2018. https://doi.org/10.1002/prca.201800010 .
Delgado-Povedano MM, Castillo-Peinado LS, Calderon-Santiago M, de Castro MDL, Priego-Capote F. Dry sweat as sample for metabolomics analysis. Talanta. 2020. https://doi.org/10.1016/j.talanta.2019.120428 .
Zhou ZP, Alvarez D, Milla C, Zare RN. Proof of concept for identifying cystic fibrosis from perspiration samples. PNAS. 2019;116(49):24408–12.
Adewole OO, Erhabor GE, Adewole TO, Ojo AO, Oshokoya H, Wolfe LM, et al. Proteomic profiling of eccrine sweat reveals its potential as a diagnostic biofluid for active tuberculosis. Proteom Clin Appl. 2016;10(5):547–53.
Jia M, Chew WM, Feinstein Y, Skeath P, Sternberg EM. Quantification of cortisol in human eccrine sweat by liquid chromatography - tandem mass spectrometry. Analyst. 2016;141(6):2053–60.
Samant PP, Prausnitz MR. Mechanisms of sampling interstitial fluid from skin using a microneedle patch. PNAS. 2018;115(18):4583–8.
Kolluru C, Williams M, Chae J, Prausnitz MR. Recruitment and collection of dermal interstitial fluid using a microneedle patch. Adv Healthc Mater. 2019. https://doi.org/10.1002/adhm.201801262 .
Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13(9):731–40.
Cornelis MC, Kacprowski T, Menni C, Gustafsson S, Pivin E, Adamski J, et al. Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior. Hum Mol Genet. 2016;25(24):5472–82.
Benowitz NL, Jacob P, Mayan H, Denaro C. Sympathomimetic effects of paraxanthine and caffeine in humans. Clin Pharmacol Ther. 1995;58(6):684–91.
Jadoon S, Karim S, Akram MR, Kalsoom Khan A, Zia MA, Siddiqi AR, et al. Recent developments in sweat analysis and its applications. Int J Anal Chem. 2015. https://doi.org/10.1155/2015/164974 .
Johnson HL, Maibach HI. Drug excretion in human eccrine sweat. J Invest Dermatol. 1971;56(3):182–8.
Kucera R, Pecen L, Topolcan O, Dahal AR, Costigliola V, Giordano FA, et al. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions. Epma J. 2020;11(3):399–418.
Jadoon S, Karim S, Akram MR, Kalsoom Khan A, Zia MA, Siddiqi AR, et al. Recent developments in sweat analysis and its applications. Int J Anal Chem. 2015;2015:164974.
Liu J, Lu YF, Corton JC, Klaassen CD. Expression of cytochrome P450 isozyme transcripts and activities in human livers. Xenobiotica. 2020. https://doi.org/10.1080/00498254.2020.1867929.
Forrester LM, Henderson CJ, Glancey MJ, Back DJ, Park BK, Ball SE, et al. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem J. 1992;281(2):359–68.
Muqaku B, Tahir A, Klepeisz P, Bileck A, Kreutz D, Mayer RL, et al. Coffee consumption modulates inflammatory processes in an individual fashion. Mol Nutr Food Res. 2016;60(12):2529–41.
Gerner C, Costigliola V, Golubnitschaja O. Multiomic patterns in body fluids: technological challenge with a great potential to implement the advanced paradigm of 3p medicine. Mass Spectrom Rev. 2020;39(5–6):442–51.
Koklesova L, Liskova A, Samec M, Qaradakhi T, Zulli A, Smejkal K, et al. Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine. EPMA J. 2020;11(2):261–87.
Samec M, Liskova A, Koklesova L, Samuel SM, Zhai K, Buhrmann C, et al. Flavonoids against the Warburg phenotype-concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism. EPMA J. 2020;11(3):377–98.
Gerner MC, Bileck A, Janker L, Ziegler LS, Ohlinger T, Raeven P, et al. Packed red blood cells inhibit T-cell activation via ROS-dependent signaling pathways. J Biol Chem. 2021. https://doi.org/10.1016/j.jbc.2021.100487 .
Baker LB. Physiology of sweat gland function: the roles of sweating and sweat composition in human health. Temperature. 2019;6(3):211–59.
Sempionatto JR, Lin M, Yin L, De la Paz E, Pei K, Sonsa-Ard T, et al. An epidermal patch for the simultaneous monitoring of haemodynamic and metabolic biomarkers. Nat Biomed Eng. 2021. https://doi.org/10.1038/s41551-021-00685-1 .
Niederstaetter L, Neuditschko B, Brunmair J, Janker L, Bileck A, Del Favero G, et al. Eicosanoid content in fetal calf serum accounts for reproducibility challenges in cell culture. Biomolecules. 2021. https://doi.org/10.3390/biom11010113 .
We acknowledge support by the Mass Spectrometry Centre of the Faculty of Chemistry, University of Vienna, and the Joint Metabolome Facility, University of Vienna and Medical University of Vienna. Both facilities are members of the Vienna Life Science Instruments (VLSI). We would also like to thank the Hochschuljubiläumsstiftung (HJS) for their financial support during the course of this research project. Figure 3 was created with the help of the Mind the Graph platform (www.mindthegraph.com) and Servier Medical Art (www.servier.com).
Open access funding provided by University of Vienna.
This study was approved by the ethical committee of the University of Vienna (no. 00337).
Consent to participate
Volunteers have given their written, informed consent to participate in this study.
Consent for publication
Volunteers have given their written, informed consent for publishing the data.
Conflict of interest
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Below is the link to the electronic supplementary material.
About this article
Cite this article
Brunmair, J., Bileck, A., Stimpfl, T. et al. Metabo-tip: a metabolomics platform for lifestyle monitoring supporting the development of novel strategies in predictive, preventive and personalised medicine. EPMA Journal 12, 141–153 (2021). https://doi.org/10.1007/s13167-021-00241-6
- Individualised metabolomics
- Mass spectrometry
- Molecular patterns
- Predictive preventive personalised medicine (PPPM)
- Risk assessment